Julie Hill

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
3.0
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Julie Hill's trades of Hikma Pharmaceuticals PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-06 2026-05-05 B Purchase
55,246
341.12
£105,878
55,246 341.12 £105,878
2024-09-24 2024-09-23 B Purchase
93,809
483.15
£141,865
93,809 483.15 £141,865
2024-05-09 2024-05-07 B Purchase
11,121
364.53
£279,371
11,121 364.53 £279,371
2024-05-09 2024-05-03 B Purchase
1
19.34
£19
1 19.34 £19